Viewing Study NCT05039450


Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2025-12-28 @ 6:32 PM
Study NCT ID: NCT05039450
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-09
First Post: 2021-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
Sponsor: Akero Therapeutics, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module